Search
Atirmociclib
go.drugbank.com/drugs/DB21733InvestigationalAtirmociclib has a monoisotopic molecular weight of 463.18 Da.
Plosaracetam
go.drugbank.com/drugs/DB21594InvestigationalPlosaracetam has a monoisotopic molecular weight of 330.05 Da.
Olomorasib
go.drugbank.com/drugs/DB21697InvestigationalOlomorasib has a monoisotopic molecular weight of 528.08 Da.
Istisociclib
go.drugbank.com/drugs/DB21703InvestigationalIstisociclib has a monoisotopic molecular weight of 287.21 Da.
Coltuximab ravtansine
go.drugbank.com/drugs/DB06342InvestigationalColtuximab ravtansine (SAR3419) targets CD19 and is being investigated for the treatment of acute lymphoblastic leukemia (ALL).
NOV-002
go.drugbank.com/drugs/DB05393InvestigationalNOV-002, the lead compound acts as a chemoprotectant and an immunomodulator, in combination with chemotherapy.
IDD-1
go.drugbank.com/drugs/DB05439ExperimentalAs with other monoclonal antibodies, this process stimulates an immune response to a particular disease-related antigen.
NTLA-2002
go.drugbank.com/drugs/DB17597InvestigationalIt is an investigational therapy designed to knock out the target gene kallikrein B1 (KLKB1) to reduce plasma kallikrein activity, thereby preventing hereditary angioedema attacks.[L45738]
mRNA-3927
go.drugbank.com/drugs/DB17669InvestigationalmRNA-3927 is an investigational mRNA therapy that consists of two mRNAs that encode for the alpha and beta subunits of the mitochondrial enzyme propionyl-CoA carboxylase (PCC) encapsulated within a lipid
3-Acetylpyridine Adenine Dinucleotide
go.drugbank.com/drugs/DB03363ExperimentalIt is found widely in nature and is involved in numerous enzymatic reactions in which it serves as an electron carrier by being alternately oxidized (NAD+) and reduced (NADH). (Dorland, 27th ed)